Opinion: CVS’ drug-price plan lets pharma off too easy

CVS HEALTH CORP. released a report last week pushing back on accusations that the company and its peers reap excessive profits as they negotiate drug prices on behalf of clients such as insurers. / BLOOMBERG NEWS FILE PHOTO/CHRISTOPHER LEE
CVS HEALTH CORP. released a report last week pushing back on accusations that the company and its peers reap excessive profits as they negotiate drug prices on behalf of clients such as insurers. / BLOOMBERG NEWS FILE PHOTO/CHRISTOPHER LEE
NEW YORK - The pharmacy benefit management business is under attack. And these middlemen of the arcane United States drug-pricing system are preparing their defenses. PBM giant CVS Health Corp. released a report last week pushing back on accusations that the company and its peers reap excessive profits as they negotiate drug prices on behalf of clients…
To read the full story, Subscribe or
Subscribe to PBN
- Advertisement -